vimarsana.com

Latest Breaking News On - Jolla pharmaceutical - Page 1 : vimarsana.com

North American Morning Briefing: Post-CPI Mood -2-

North American Morning Briefing: Post-CPI Mood -2-
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Black Diamond Therapeutics (NASDAQ:BDTX) and La Jolla Pharmaceutical (NASDAQ:LJPC) Head to Head Survey

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) and La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends. Volatility & Risk Black Diamond Therapeutics has […]

Financial Analysis: Brookline Capital Acquisition (NASDAQ:BCAC) vs La Jolla Pharmaceutical (NASDAQ:LJPC)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

North American Morning Briefing: Tech Futures -2-

North American Morning Briefing: Tech Futures -2-
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

La Jolla Pharmaceutical (NASDAQ:LJPC) Now Covered by StockNews com

StockNews.com began coverage on shares of La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) in a research note issued to investors on Thursday. The firm set a “buy” rating on the biopharmaceutical company’s stock. Separately, Zacks Investment Research downgraded La Jolla Pharmaceutical from a “buy” rating to a “hold” rating in a report on Wednesday, January […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.